Skip to main content
UNC Lineberger Comprehensive Cancer Center

Donors & Funding

Philanthropic Organizations

 

She ROCKS logo - Research Ovarian Cancer Knowledge Support Fighting Cancer Below the Belt logo   Golfing for the Gals logoDina's Dynasty logoBecky Black Memorial Fund

Active Grants

  1. Pembrolizumab and ONC201 as a Novel Treatment Strategy in Obesity-driven Endometrial Cancer  (UNC Lineberger Comprehensive Cancer Center)
  2. Impact of Obesity on Immuno-Oncology Agents in Endometrial Cancer (NIH/NCI)
  3. Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence: SISTER Study (Patient-Centered Outcomes Research Institute)
  4. Advancing Women’s Health Through Research: The UNC WRHR Career Development Program (NIH)
  5. Pembrolizumab and ONC201 as a Novel Treatment Strategy in Obesity-driven Endometrial Cancer (UNC Lineberger Comprehensive Cancer Center)
  6. Endometrial Cancer Molecularly Targeted Therapy Consortium (Kay Yow Cancer Fund/V Foundation for Cancer Research)
  7. Cellular Immunotherapy of Ovarian Cancer (NIH/NCI)
  8. Interval exercise training as a therapy for endometrial cancer (NIH/NCI)
  9. Window of Opportunity Study of Pembrolizumab in Early Stage, High Grade Obesity-driven Endometrial Cancer (Merck)
  10. Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in  Endometrial Cancer (NIH/NCI)
  11. Metabolic and Molecular Biomarkers of Metformin Response in Obesity-driven Endometrial Cancer (V Foundation)

Completed Grants

  1. Impact of Race, Obesity and the Microbiome on Endometrial Cancer Treatment (Foundation for Women’s Cancers)
  2. Pre-clinical Assessment of Induced Neural Stem Cells as Innovative Therapy for Ovarian Cancer (Foundation for Women’s Cancers)
  3. Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy (NIH/NCI)
  4. Inter-relationship between microbiota diversity, obesity and race in endometrial cancer (NIH/NCI)
  5. Network Group Integrated Translational Science Centers Application (NCI)
  6. The MOVES Trial: MOtiVating Endometrial Cancer Survivors with Text Messaging (UNC Lineberger Comprehensive Cancer Center)
  7. Obesity, Cation-Selective Transporters and Metformin in Endometrial Cancer (American Cancer Society)
  8. Association between Volume of Endometrial Carcinoma Disease Spread and Clinical and Molecular factors (Wilma Williams Education and Clinical Research for Endometrial Cancer)
  9. Discovery of Novel, Efficacious and Safe Biguanides for the Treatment of Ovarian Cancer (NCBC)
  10. Evaluating the Endometrium of Endometrial Cancer Patients: A Pre-Operative Window Study (Wilma Williams Education and Clinical Research for Endometrial Cancer)
  11. Translating Healthy Lifestyle Interventions for Breast and Endometrial Cancer Survivors with Diabetes (NIDDK)
  12. Transporters in Metformin Treatment of Endometrial Hyperplasia (NIH/NCI)
  13. Metformin and the Levonorgesterol-Releasing Intrauterine Device for the Treatment of Non-Surgical Patients with Endometrial Hyperplasia and Endometrial Cancer (Golfers Against Cancer Research Award)
  14. Preclinical and Clinical Investigation of the Impact of Obesity on Ovarian Cancer Pathogenesis (DOD/OCRP)
  15. Obesity Across the Lifespan on Ovarian Cancer Pathogenesis (DOD/OCRP)
  16. Metformin as a Novel Chemotherapeutic Strategy for the Treatment of Endometrial Cancer (NIH/NCI K23)
  17. Obesity, Cation-Selective Transporters and Metformin in Endometrial Cancer (AAOGF)
  18. Evaluation of Mediators of Mononuclear Phagocyte System (MPS) Function and Nanoparticle Pharmacology in Obese and Non-Obese Patients with Ovarian and Endometrial Cancer enrolled on the UNC Cancer Survivorship Cohort (UNC Lineberger Comprehensive Cancer Center)
  19. Circulating Tumor Cells and Ovarian Cancer (Golfers Against Cancer Research Award)
  20. Metformin for the Treatment of Endometrial Hyperplasia (UNC Lineberger Comprehensive Cancer Center)
  21. Metformin for the Treatment of Endometrial Hyperplasia (ASCO)
  22. Web-based 24h recalls to assess habitual diet among cancer survivors: A feasibility study (NC Cancer Hospital Endowment Fund)
  23. Investigation of the Impact of Obesity and Metformin on Ovarian Cancer Pathogenesis (UNC Nutrition Obesity Research Center)
  24. Cross-species investigation of the impact of obesity on ovarian cancer pathogenesis (Gynecologic Cancer Foundation, Florence & Marshall Schwid Ovarian Cancer Grant)
  25. Obesity, Metformin and Ovarian Cancer Pathogenesis (NC TraCS)
  26. A Molecular Pathway to Therapeutic Intervention and Individualized Treatment for Endometrial Cancer (UNC UCRF)
  27. Metformin as a Novel Chemotherapeutic Strategy for the Treatment of Endometrial Cancer (V Foundation)
  28. Preclinical in vitro and in vivo evaluation of mTOR inhibitors in combination with multiple chemotherapeutic agents used for the treatment of endometrial cancer (Multidisciplinary Clinical Research Career Development Roadmap K12 Scholar)
  29. Rationale for mTOR Inhibitors and Progestins as a Potential Combined Therapeutic Strategy for Endometrial Cancer (UNC University Research Council Award)
  30. The Relationship between Obesity, Insulin Resistance and Innate Immunity in Endometrial Cancer (UNC Excellence Fund)
  31. A Pathway to Therapeutic Treatment and Early Detection of Human Epithelial Ovarian Cancer (Marsha Rivkin Center)
  32. Preclinical evaluation of genistein and soy extract in combination with conventional cytotoxic and hormonal treatment regimens for endometrial cancer (CEHS)
  33. Rationale for mTOR Inhibitors and Progestins as a Potential Combined Therapeutic Strategy for Endometrial Cancer (UNC Junior Faculty Development Award)